Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy-Reference-Cited by-同舟云学术

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Published:2014 Issue: Volume:1 Page:14006
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Vähä-Koskela Markus,Tähtinen Siri,Grönberg-Vähä-Koskela Susanna,Taipale Kristian,Saha Dipongkor,Merisalo-Soikkeli Maiju,Ahonen Marko,Rouvinen-Lagerström Noora,Hirvinen Mari,Veckman Ville,Matikainen Sampsa,Zhao Fang,Pakarinen Päivi,Salo Jarmo,Kanerva Anna,Cerullo Vincenzo,Hemminki Akseli

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference49 articles.

1. Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways;Naik;Expert Opin Biol Ther,2009

2. Oncolytic viruses for induction of anti-tumor immunity;Tong;Curr Pharm Biotechnol,2012

3. Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus;Kanerva;Clin Cancer Res,2013

4. Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data;Pesonen;Mol Pharm,2011

5. From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development;Crompton;Curr Cancer Drug Targets,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotherapeutics targeting autophagy regulation for improved cancer therapy;Acta Pharmaceutica Sinica B;2024-06

2. Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis;Vaccines;2021-10-12

3. Pathogenetic Features and Current Management of Glioblastoma;Cancers;2021-02-18

4. New viral vectors for infectious diseases and cancer;Seminars in Immunology;2020-08

5. Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series;Frontiers in Oncology;2020-05-14